Viewing Study NCT07202533


Ignite Creation Date: 2025-12-25 @ 3:03 AM
Ignite Modification Date: 2026-01-06 @ 4:09 AM
Study NCT ID: NCT07202533
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-01
First Post: 2025-09-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pain Neuroscience Education and Exercise for Chronic Nonspecific Low Back Pain
Sponsor: Hacettepe University
Organization:

Study Overview

Official Title: Investigation of the Effectiveness of Exercise and Pain Neuroscience Education in Individuals With Chronic Nonspecific Low Back Pain With Central Sensitization
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2025-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aims to evaluate the effects of adding Pain Neuroscience Education (PNE) to motor control exercises in individuals with chronic non-specific low back pain (CNSLBP) who also present with central sensitization. The study focuses on changes in pain intensity, pain-related factors, trunk muscle activation, gait, functionality, kinesiophobia, and quality of life.
Detailed Description: This randomized controlled study aims to investigate the effects of combining PNE with motor control exercises in individuals with CNSLBP who demonstrate central sensitization (≥28 points on the Central Sensitization Inventory). Participants are randomly assigned into two groups: the intervention group (motor control exercises + PNE) and the control group (motor control exercises only). Both groups participate in motor control exercises twice a week for 8 weeks, under the supervision of a physiotherapist. The intervention group additionally receives six PNE sessions once per week for six weeks. PNE sessions are delivered by a certified physiotherapist using interactive presentations and question-answer discussions.

Assessments are performed pre- and post-intervention using the following tools:

* Central Sensitization Inventory (CSI) to determine the presence and severity of central sensitization.
* Numeric Pain Rating Scale (NPRS) for pain intensity.
* Revised Neurophysiology of Pain Questionnaire (rNPQ) for pain knowledge.
* Pain Catastrophizing Scale (PCS) for catastrophic thinking.
* Pressure Pain Threshold (PPT) using a digital algometer.
* Electromyographic (EMG) evaluation of trunk and lower extremity muscles using surface electrodes.
* Spatiotemporal gait analysis using OptoGait and Ultium Insole systems.
* Tampa Scale for Kinesiophobia (TSK) for fear of movement.
* Roland-Morris Disability Questionnaire (RMDQ) for disability level.
* Nottingham Health Profile (NHP) for quality of life.

Data will be analyzed using SPSS version 27. Normality of distribution will be tested with the Shapiro-Wilk test. Depending on the distribution, either parametric (paired t-test, independent t-test) or non-parametric tests (Wilcoxon signed-rank, Mann-Whitney U) will be applied. Pearson or Spearman correlation analyses will be used where appropriate.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: